Thymosin-Alpha 1

Thymosin Alpha-1 (often abbreviated as TA1 or Ta1) is a naturally occurring peptide produced by the thymus gland. Composed of 28 amino acids, its primary function is to enhance immune system performance by stimulating key immune cells and processes.

​

Primary Benefits

• Increases T-cell production (up to 30%)

• Boosts natural killer cell activity

• Replenishes white blood cell count

• Helps combat viral infections

• Enhances vaccine effectiveness

• Anti-inflammatory effects

• Supports cancer treatment protocols

• Promotes healing and tissue repair

• Stimulates angiogenesis (formation of new blood vessels)

• Antioxidant support via glutathione peroxidase and dismutase

• Enhances cell-mediated immunity

• May reduce viral load in hepatitis and HIV

• May improve chemotherapy outcomes

​

Who Benefits from TA1 Therapy

• Individuals with weakened immune systems

• Those with autoimmune disorders

• Aging adults (thymus size and TA1 levels naturally decline with age)

• Anyone wanting to improve vaccine responsiveness

​

Possible Side Effects (rare, generally mild)

• Injection site irritation (redness, swelling, itching)

• Fever

• Muscle aches

• Fatigue

• Nausea

• Vomiting